RCL three-lens brief
Evidence-based stock research on RCL. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 11.0pp over 30 days. · Negative free cash flow last quarterly (-$194.88M).
- Underperforming SPY by 11.0pp over 30 days.
- Analyst mean target $342.52 — 30% above current (23 analysts).
- Negative free cash flow last quarterly (-$194.88M).
- Debt-to-equity of 217.3 — balance-sheet-heavy.
RCL closed at $264.39 (-0.44%) as of 2026-05-04. Market cap: $71.52B. P/E (trailing) 16.1. Positives: analyst mean target $342.52 — 30% above current (23 analysts).. Concerns: underperforming SPY by 11.0pp over 30 days.; negative free cash flow last quarterly (-$194.88M).. Last quarter: Revenue $4.45B, net income $941.00M, free cash flow -$194.88M.
Why three lenses on RCL, not one.
A single reasoning model has blind spots it doesn’t know about. We examine RCLacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/RCL" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath RCL brief"></iframe>